Protection of pyrroloquinoline quinone againts methylmercury-induced neurotoxicity via reducing oxidative stress

Free Radical Research

Volumn 43, Issue 3, 2009, Pages 224-233

  Zhang, Peng ^a   Xu, Yongping ^a   Sun, Jingxian ^b   Li, Xiaoyu ^a   Wang, Linhui ^a   Jin, Liji ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b DALIAN OCEAN UNIVERSITY   (China)

Author keywords

Antioxidant; Apoptosis; Methylmercury; Neuroprotection; Oxidative stress; Pyrroloquinoline quinone

Indexed keywords

LIPID; METHYLMERCURY; PYRROLOQUINOLINEQUINONE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; LIPID PEROXIDATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; RAT;

ANIMALS; APOPTOSIS; CATALASE; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MERCURY POISONING, NERVOUS SYSTEM; METHYLMERCURY COMPOUNDS; NEURONS; OXIDATIVE STRESS; PC12 CELLS; PQQ COFACTOR; RATS; SUPEROXIDE DISMUTASE;

EID: 61849143250     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760802677348     Document Type: Article

References (53)

1. Mahaffey, KR. (2000) Recent advances in recognition of low level methylmercury poisoning. Curr Opin Neurol, 13, pp. 699-707.
2. Carta, P., Flore, C., Alinovi, R., Ibba, A., Tocco, MG, Aru, G., Carta, R., Girei, E., Mutti, A., Lucchini, R. and Randaccio, FS. (2003) Subclinical neurobehavioral abnormalities associated with low level of mercury exposure through fish consumption. Neurotoxicology, 24, pp. 617-623.
3. Grandjean, P., Murata, K., Budtz-Jorgensen, E. and Weihe, P. (2004) Cardiac autonomic activity in methylmercury neurotoxicity: 14-year follow-up of a Faroese birth cohort. J Pediatr, 144, pp. 169-176.
4. Reuhl, KR and Chang, LW. (1979) Effects of methylmercury on the development of the nervous system: A review. Neurotoxicology, 1, pp. 21-55.
5. Takeuchi, T., Kambara, T., Marikawa, N., Matsumoto, H., Shiraishi, Y. and Ito, H. (1959) Pathologic observation of the Minamata disease. Acta Pathol Jpn, 9, pp. 769-783.
6. Kunimoto, M. (1994) Methylmercury induces apoptosis of rat cerebellar neurons in primary culture. Biochem Biophys Res Commun, 204, pp. 310-317.
7. Sanfeliu, C., Sebastia, J. and Kim, SU. (2001) Methylmercury neurotoxicity in cultures of human neurons, astrocytes, neuroblastoma cells. Neurotoxicology, 22, pp. 317-327.
8. Sarafian, T. and Verity, MA. (1991) Oxidative mechanisms underlying methylmercury neurotoxicity. Int J Dev Neurosci, 9, pp. 147-153.
9. Kasuya, M. (1976) Effect of selenium on the toxicity of methylmercury on nervous tissue in culture. Toxicol Appl Pharmacol, 35, pp. 11-20.
10. Dare, E., Gotz, ME, Zhivotovsky, B., Manzo, L. and Ceccatelli, S. (2000) Antioxidants J811 and 17beta-estradiol protect cerebellar granule cells from methylmercury-induced apoptotic cell death. J Neurosci Res, 62, pp. 557-565.
11. Park, ST, Lim, KT, Chung, YT and Kim, SU. (1996) Methylmercury induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Neurotoxicology, 17, pp. 37-45.
12. Naganuma, A., Miura, K., Tanaka-Kagawa, T., Kitahara, J., Seko, Y., Toyoda, H. and Imura, N. (1998) Overexpression of manganese-superoxide dismutase prevents methylmercury toxicity in HeLa cells. Life Sci, 62, pp. 157-161.
13. Goodwin, PM and Anthony, C. (1998) The biochemistry, physiology and genetics of PQQ and PQQ-containing enzymes. Adv Microb Physiol, 40, pp. 1-80.
14. Westerling, J., Frank, J. and Duine, JA. (1979) The prosthetic group of methanol dehydrogenase from Hyphomicrobium X: Electron spin resonance evidence for a quinone structure. Biochem Biophys Res Commun, 87, pp. 719-724.
15. Salisbury, SA, Forrest, HS, Cruse, WB and Kennard, O. (1979) A novel coenzyme from bacterial primary alcohol dehydrogenases. Nature, 280, pp. 843-844.
16. Corey, EJ and Tramontano, A. (1981) Total synthesis of the quinonoid alcohol dehydrogenase coenzyme (1) of methylotrophic bacteria. J Am Chem Soc, 103, pp. 5599-5600.
17. Kumazawa, T., Seno, H., Urakami, T., Matsumoto, T. and Suzuki, O. (1992) Trace levels of pyrroloquinoline quinone in human and rat samples deteceted by gas chromatography/mass spectrometry. Biochim Biophys Acta, 1156, pp. 62-66.
18. Kumazawa, T., Sato, K., Seno, H., Ishii, A. and Suzuki, O. (1995) Levels of pyrroloquinoline quinone in various foods. Biochem J, 307, pp. 331-333.
19. Steinberg, FM, Gershwin, E. and Rucker, RB. (1994) Dietary pyrroloquinoline quinone: Growth and immune response in BALB/c mice. J Nutr, 124, pp. 744-753.
20. Kasahara, T. and Kato, T. (2003) Nutritional biochemistry: A new redox cofactor vitamin for mammals. Nature, 422, p. 832.
21. Aizenman, E., Hartnett, KA, Zhong, C., Gallop, PM and Rosenberg, PA. (1992) Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site. J Neurosci, 12, pp. 2362-2369.
22. Aizenman, E., Jensen, FE, Gallop, PM, Rosenberg, PA and Tang, LH. (1995) Further evidence that pyrroloquinoline quinone interacts with the N-methyl-D-aspartate receptor redox site in rat cortical neurons in vitro. Neurosci Lett, 168, pp. 189-192.
23. Jensen, FE, Gardner, GJ, Williams, AP, Gallop, PM, Aizenman, E. and Rosenberg, PA. (1994) The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience, 62, pp. 399-406.
24. Zhang, Y. and Rosenberg, PA. (2002) The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur J Neurosci, 16, pp. 1015-1102.
25. Zhang, Y., Feustel, PJ and Kimelberg, HK. (2006) Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res, 1094, pp. 200-206.
26. Hara, H., Hiramatsu, H. and Adachi, T. (2007) Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem Res, 32, pp. 489-495.
27. Smidt, CR, Unkefer, CJ, Houck, DR and Rucker, RB. (1991) Intestinal absorption and tissue distribution of [14C] pyrroloquinoline quinone in mice. Proc Soc Exp Biol Med, 197, pp. 27-31.
28. Greene, LA and Tischler, AS. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Nati Acad Sci USA, 73, pp. 2424-2428.
29. Igata, A. (1993) Epidemiological and clinical features of minamata disease. Environ Res, 63, pp. 157-169.
30. Harada, M. (1995) Minamata disease: Methylmercury poisoning in japan caused by environmental pollution. Crit Rev Toxicol, 25, pp. 1-24.
31. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survivals: Application to proliferation and cytotoxicity assays. J Immunol Methods, 65, pp. 55-63.
32. Vindelov, LL, Christensen, IJ and Nissen, NI. (1983) Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry, 3, pp. 328-331.
33. Miura, K., Koide, N., Himeno, S., Nakagawa, I. and Imura, N. (1999) The Involvement of microtubular disruption in methylmercury-induced apoptosis in neuronal and nonneuronal cell lines. Toxicol Appl Pharmacol, 160, pp. 279-288.
34. Walton, M., Sirimanne, E., Reutelingsperger, C., Williams, C., Gluckman, P. and Dragunow, M. (1997) Annexin-V labels apoptotic neurons following hypoxiaischemia. Neuroreport, 8, pp. 3871-3875.
35. Manosroi, A., Saraphanchotiwitthaya, A. and Manosroi, J. (2005) In vitro immunomodulatory effect of Pouteria cambodiana (Pierre ex Dubard) Baehni extract. J Ethnopharmacol, 101, pp. 90-94.
36. Bakir, F., Damluji, SF, Amin-Zaki, L., Murtadha, M., Khalidi, A., Al-Rawi, NY, Tikriti, S., Dahahir, HI, Clarkson, TW, Smith, JC and Doherty, RA. (1973) Methylmercury poisoning in Iraq. Science, 181, pp. 230-241.
37. Choi, BH. (1989) The effects of methylmercury on the developing brain. Prog Neurobiol, 32, pp. 447-470.
38. Clarkson, TW, Magos, L. and Myers, GJ. (2003) The toxicology of mercury-current exposures and clinical manifestation. N Engl J Med, 349, pp. 1731-1737.
39. He, K., Nukada, H., Urakami, T. and Michael, PM. (2003) Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): Implications for its function in biological systems. Biochem Pharmacol, 65, pp. 67-74.
40. Hiraku, Y. and Kawanishi, S. (1996) NADH-mediated DNA damage induced by a new coenzyme, pyrroloquinoline quinone, in the presence of copper(II) ion. FEBS Lett, 393, pp. 317-320.
41. Watanabe, A., Hobara, N., Ohsawa, T., Higashi, T. and Tsuji, T. (1989) Nephrotoxicity of pyrroloquinoline quinone in rats. Hiroshima J Med Sci, 38, pp. 49-51.
42. Castoldi, AF, Barni, S., Turin, I., Gandini, C. and Manzo, L. (2000) Early acute necrosis, delayed apoptosis and cytoskeletal breakdown in cultured cerebellar granule neurons exposed to methylmercury. J Neurosci Res, 59, pp. 775-787.
43. Ali, SF, LeBel, CP and Bondy, SC. (1992) Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology, 13, pp. 637-648.
44. Park, ST, Lim, KT, Chung, YT and Kim, SU. (1996) Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Neurotoxicology, 17, pp. 37-45.
45. Sarafian, TA. (1999) Methylmercury-induced generation of free radicals: biological implications. Metal Ions Biol Syst, 36, pp. 415-444.
46. Sorg, O., Schilter, B., Honnegger, P. and Monnet-Tschudi, F. (1998) Increased vulnerability of neurones and glial cells to low concentrations of methylmercury in a prooxidant situation. Acta Neuropathol, 96, pp. 621-627.
47. Aslan, R., Sekeroglu, MR, Gultekin, F. and Bayiroglu, F. (1997) Blood lipoperoxidation and antioxidant enzymes in healthy individuals: relation to age, sex, habits, life style and environment. J Environ Sci Health A, 32, pp. 2101-2109.
48. Zhang, YT, Zheng, QS, Pan, J. and Zheng, RL. (2004) Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants. Basic Clin Pharmacol Toxicol, 95, pp. 53-58.
49. Urakami, T., Yoshida, C., Akaike, T., Maeda, H., Nishigori, H. and Niki, E. (1997) Synthesis of monoesters of pyrroloquinoline quinone and imidazo-pyrroloquinoline, and radical scavenging activities using electron spinresonance in vitro and pharmacological activity in vivo. J Nutr Sci Vitaminol (Tokyo), 43, pp. 19-33.
50. Hamagishi, Y., Murata, S., Kamei, H., Oki, T., Adachi, O. and Ameyama, M. (1990) New biological properties of pyrroloquinoline quinone and its related compounds: Inhibition of chemiluminescence, lipid peroxidation and rat paw edema. J Pharmacol Exp Ther, 255, pp. 980-985.
51. Xu, F., Mack, CP, Quandt, KS, Shlafer, M., Massey, V. and Hultquist, DE. (1993) Pyrroloquinoline quinone acts with flavin reductase to reduce ferryl myoglobin in vitro and protects isolated heart from re-oxygenation injury. Biochem Biophys Res Commun, 193, pp. 434-439.
52. Kono, Y. and Fridovich, I. (1982) Superoxide radical inhibits catalase. J Biol Chem, 257, pp. 5751-5754.
53. 2. Arch Biochem Biophys, 212, pp. 411-416.